BioPharma’s Canadian operations will continue to operate in accordance with public health guidelines to provide vital medical research and clinical trials.
All
News
A message from our chief executive officer Renzo Dicarlo
BioPharma Services Inc. has established a cross-functional COVID-19 taskforce with representation from senior leadership and experts across the company.
FDA Guidance on Conduct of Clinical Trials During COVID-19 Pandemic
The US Food and Drug Administration (FDA) has issued new guidance to ensure the safety of volunteers in clinical trials during the global COVID-19 pandemic.
Biopharma services donates clinical resources scientific expertise for coronavirus vaccine research
BioPharma Services has decided to donate its WHO approved facility for coronavirus or COVID-19 vaccine research and treatments.
Happy Holidays!
BioPharma Services Inc., a global Contract Research Organization (CRO), wishes you and your families a safe, happy and joyous holiday season ahead!
BioPharma Services INC. Successfully Completes Another Round Of FDA Inspections With Zero Form 483s
Since 2009, the US FDA has conducted 13 GCP Inspections of BioPharma Services Inc. without a single Form 483 issued.